不同病理状态下脑脊液生成率的初步研究
这项前瞻性观察研究于2021年9月起在英国国家神经病学与神经外科医院开展,用LiquoGuard7泵测量164例需脑脊液引流患者的脑脊液生成率。多数病理状态下测得的生成率高于传统假设的正常范围,作者认为传统脑脊液生成与循环认识不能解释这些发现,需更广泛研究验证该技术。
要点
- 用LiquoGuard7泵测量164例患者的净脑脊液生成率,多数高于传统假设的正常范围。
- 蛛网膜下腔出血组生成率143ml/h±9SD,脑出血组137ml/h±20SD,均与假设正常值差异有统计学意义(p<0.0001)。
- 垂体腺瘤组生成率29ml/h±9SD,为所报告各组中最低,与假设正常值差异有统计学意义(p<0.049)。
核心结论
- 作者认为许多病理状态下净脑脊液生成率可能高于预期,以LiquoGuard7通过净流量测得,可能对脑脊液分流临床决策有启示。
- 作者指出传统脑脊液生成与循环认识不能解释本研究发现,需更广泛研究验证该技术。
研究设计与样本
- 前瞻性观察研究,自2021年9月起纳入英国国家神经病学与神经外科医院所有因持续治疗需脑脊液引流的患者。
- 外引流管连接LiquoGuard7泵(Möller Medical GmbH,富尔达,德国),用其内置软件测量脑脊液生成率。
- 共计算164例患者的脑脊液生成率。
- 统计分析用SPSS 25.0(IBM)行配对t检验,将测得率与Ekstedt发表的计算假设正常脑脊液生成率(16-34ml/h)比较,假定分布相似。
主要发现
- 疑似正常压力脑积水(n=41):脑脊液生成率79ml/h±20SD(p<0.0001)。
- 术后脑脊液漏(n=26):脑脊液生成率90ml/h±20SD(p<0.0001)。
- 蛛网膜下腔出血(n=34):脑脊液生成率143ml/h±9SD(p<0.0001)。
- 脑出血(n=22):脑脊液生成率137ml/h±20SD(p<0.0001)。
- 脊髓病变(n=7):脑脊液生成率130ml/h±20SD(p<0.0032);垂体腺瘤(n=10):29ml/h±9SD(p<0.049);特发性颅内高压(n=15):86ml/h±10SD(p<0.0001);失代偿性长期明显脑室扩大(n=4):65ml/h±10SD(p<0.0001);脑感染(n=5):90ml/h±20SD(p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需更广泛研究验证该技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The cerebrospinal fluid (CSF) production rate in humans is not clearly defined but is estimated to be 18-24 ml/h (Trevisi et al Croat Med J 55(4):377-387 (24); Casey and Vries Childs Nerv Syst 5(5):332-334 (8)). A frequent clinical observation is that patients often drain higher volumes of CSF than can be explained by the assumed 'normal' CSF production rate (PRcsf). In the National Hospital for Neurology and Neurosurgery PRcsf was recorded in a variety of common neurosurgical pathologies using LiquoGuard7, an automated peristaltic pump that accurately controls CSF drainage and maintains a pre-set CSF pressure. METHODS: A prospective observational study was performed from September 2021 onwards, on all patients in the National Hospital for Neurology and Neurosurgery who required CSF drainage as part of their ongoing treatment. The external drain was connected to a LiquoGuard7 pump (Möller Medical GmbH, Fulda, Germany), and the internal software of LiquoGuard7 was used to measure PRcsf. Statistical analysis used SPSS (version 25.0, IBM) by paired t test, comparing measured rates to hypothetical 'normal' CSF production rates calculated and published by Ekstedt (16-34ml/h) (Ekstedt J Neurol Neurosurg Psychiatry 41(4):345-353 (14)), assuming a similar distribution. RESULTS: PRcsf was calculated in 164 patients. Suspected normal pressure hydrocephalus (n=41): PRcsf of 79ml/h±20SD (p<0.0001). Post-surgical CSF leak (n=26): PRcsf of 90ml/h±20SD (p<0.0001). Subarachnoid haemorrhage (n=34): PRcsf of 143ml/h±9SD (p<0.0001). Intracerebral haemorrhage (n=22): PRcsf of 137ml/h±20SD (p<0.0001). Spinal lesions (n=7): PRcsf of 130ml/h±20SD (p<0.0032). Pituitary adenomas (n=10): PRcsf of 29 ml/h±9SD (p<0.049). Idiopathic intracranial hypertension (n=15): PRcsf of 86ml/h±10SD (p<0.0001). Decompensated long-standing overt ventriculomegaly (n=4): PRcsf of 65ml/h±10SD (p<0.0001). Cerebral infection (n=5): PRcsf of 90ml/h±20SD (p<0.0001). CONCLUSION: Net CSF production rate may be higher than expected in many conditions, as measured with new device LiquoGuard7 through the study of net flow rate, which may have implications for clinical decisions on CSF diversion. The conventional understanding of CSF production and circulation does not explain the findings of this study. More extensive studies are needed to validate this technique.
引用
- Tariq K, Toma A, Khawari S, et al. Cerebrospinal fluid production rate in various pathological conditions: a preliminary study. Acta Neurochir (Wien). 2023. PMID: 37354286. doi:10.1007/s00701-023-05650-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。